Arvinas, Inc. (ARVN) Revenue History
Annual and quarterly revenue from 2016 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ARVN Revenue Growth
Revenue Breakdown (FY 2025)
ARVN's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
ARVN Revenue Analysis (2016–2025)
As of May 6, 2026, Arvinas, Inc. (ARVN) generated trailing twelve-month (TTM) revenue of $262.6 million, reflecting significant decline in growth of -84.0% year-over-year. The most recent quarter (Q4 2025) recorded $9.5 million in revenue, down 77.3% sequentially.
Looking at the longer-term picture, ARVN's 5-year compound annual growth rate (CAGR) stands at +58.9%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $263.4 million in 2024.
Revenue diversification analysis shows ARVN's business is primarily driven by License (100%). With over half of revenue concentrated in License, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including KYMR (-12.6% YoY), MDGL (+864.2% YoY), and PTCT (+114.5% YoY), ARVN has underperformed the peer group in terms of revenue growth. Compare ARVN vs KYMR →
ARVN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ARVNCurrent | $263M | -84.0% | +58.9% | -43.8% | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% | |
 MDGL | $958M | +864.2% | - | -31.3% | |
 PTCT | $1.7B | +114.5% | +35.4% | 49.5% | |
 RCUS | $247M | +67.4% | +25.9% | -156.3% |
ARVN Historical Revenue Data (2016–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $262.6M | -0.3% | $257.4M | 98.0% | $-114,900,000 | -43.8% |
| 2024 | $263.4M | +235.5% | $263.4M | 100.0% | $-250,200,000 | -95.0% |
| 2023 | $78.5M | -40.3% | $78.5M | 100.0% | $-401,500,000 | -511.5% |
| 2022 | $131.4M | +145.1% | $131.4M | 100.0% | $-263,200,000 | -200.3% |
| 2021 | $53.6M | +106.9% | $53.6M | 100.0% | $-188,400,000 | -351.5% |
| 2020 | $25.9M | -39.7% | $25.9M | 100.0% | $-120,800,000 | -466.4% |
| 2019 | $43.0M | +200.0% | $43.0M | 100.0% | $-51,524,514 | -119.9% |
| 2018 | $14.3M | +89.0% | $14.3M | 100.0% | $-43,802,078 | -305.8% |
| 2017 | $7.6M | +13.6% | $7.6M | 100.0% | $-24,760,267 | -326.7% |
| 2016 | $6.7M | - | $6.7M | 100.0% | $-16,469,420 | -247.0% |
See ARVN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ARVN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ARVN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonARVN — Frequently Asked Questions
Quick answers to the most common questions about buying ARVN stock.
Is ARVN's revenue growth accelerating or slowing?
ARVN revenue declined -84.0% year-over-year, contrasting with the 5-year CAGR of +58.9%. TTM revenue fell to $263M. This reverses the prior growth trend.
What is ARVN's long-term revenue growth rate?
Arvinas, Inc.'s 5-year revenue CAGR of +58.9% reflects the variable expansion pattern. Current YoY growth of -84.0% is below this long-term average.
How is ARVN's revenue distributed by segment?
ARVN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2016-2025 are available for download. Segment mix reveals concentration and diversification trends.